With such an eminent authority leading the experiments no one at the time thought to question the results
Acta Diabetol (2015) 52(6):108391.10.1007/s00592-015-0792-2 14 BunckMCEliassonBCornerAHeineRJShaginianRMTaskinenMRet alExenatide treatment did not affect bone mineral density despite body weight reduction in patients with type 2 diabetes
On-demand strength-training Videos to help you retain muscle mass as you lose weight
5,6 Additionally, high glucose levels negatively impact osteoblast function, contributing to bone defects partly through the production of advanced glycation end-products (AGEs), which upregulates sclerostin, an inhibitor of osteoblast activity
Receptors can internalize or downregulate, Hardaway said
Fusco J et al (2017): GLP-1/Exendin-4 induces -cell proliferation via the epidermal growth factor receptor